AI Terminal
JENOPTIK AG
Earnings Release • Feb 14, 2023
234_rns_2023-02-14_98d7b500-85d3-4f13-96fb-1270a84d56e2.html
Earnings Release
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 9049P
Jenoptik AG
14 February 2023
JENOPTIK AG: Jenoptik provides revenue and earnings outlook for 2023
Ad-hoc | 14 February 2023 13:55
JENOPTIK AG / Key word(s): Forecast
JENOPTIK AG: Jenoptik provides revenue and earnings outlook for 2023
14-Feb-2023 / 13:55 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Based on a resolution passed by the Executive Board today, JENOPTIK AG (FSE: JEN / ISIN: DE000A2NB601) announces key figures of the guidance for fiscal year 2023. Due to the good order intake, the high order backlog, and ongoing good developments in the core photonics businesses, especially in the semiconductor equipment sector, Jenoptik is anticipating revenue of 1,050 million euros to 1,100 million euros and an EBITDA margin of 19.0 to 19.5 percent for 2023.
This guidance is based on preliminary revenue of around 980 million euros in fiscal 2022 (compared with the most recent forecast of 945 to 960 million euros). The preliminary EBITDA margin increased to around 18.8 percent, above the latest forecast of 18.0 to 18.5 percent.
If you have any further questions, please contact:
JENOPTIK AG | Investor Relations & Corporate Communications
Andreas Theisen Sabine Barnekow
Head of Investor Relations Investor Relations Manager
Phone: +49 3641 65-2291 Phone: +49 3641 65-2156
E-Mail: [email protected] E-Mail: [email protected]
This announcement can contain forward-looking statements that are based on current expectations and certain assumptions of the management of the Jenoptik Group. A variety of known and unknown risks, uncertainties and other factors can cause the actual results, the financial situation, the development or the performance of the company to be materially different from the announced forward-looking statements. Such factors can be, among others, geopolitical conflicts, pandemic diseases, changes in currency exchange rates and interest rates, the introduction of competing products or the change of the business strategy. The company does not assume any obligation to update such forward-looking statements in the light of future developments.
Contact:
Andreas Theisen
Head Investor Relations
Phone 03641-652291
14-Feb-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
| Language: | English |
| Company: | JENOPTIK AG |
| Carl-Zeiss-Straße 1 | |
| 07743 Jena | |
| Germany | |
| Phone: | +49 (0)364 165-2156 |
| Fax: | +49 (0)364 165-2804 |
| E-mail: | [email protected] |
| Internet: | www.jenoptik.com |
| ISIN: | DE000A2NB601 |
| WKN: | A2NB60 |
| Indices: | SDAX, TecDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1559581 |
| End of Announcement | EQS News Service |
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NRAKZGMZFDKGFZM